Evidence map›Paper›PMID 42088215›Full record

ArticleFrontiers in oncology2026

Synchronous bilateral phyllodes tumors with discordant grades and false-positive axillary

Tianle Yu, Ruiyong Li, Chunyu Cai

Abstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tianle YuThe Affiliated Hospital of Yanbian University (Yanbian Hospital), Yanji, China.
Ruiyong LiThe Affiliated Hospital of Yanbian University (Yanbian Hospital), Yanji, China.
Chunyu CaiThe Affiliated Hospital of Yanbian University (Yanbian Hospital), Yanji, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rationale: Phyllodes tumors are uncommon fibroepithelial breast neoplasms with variable biologic behavior. Synchronous bilateral phyllodes tumors are exceptionally rare, and the interpretation of Patient concerns: A 44-year-old Korean woman presented with a rapidly enlarging, painful, ulcerated left breast mass for 3 months. She had no nipple discharge, fever, or weight loss. A right breast lesion was clinically occult. Diagnoses: Ultrasound showed a right breast hypoechoic nodule (BI-RADS 4A) with scant vascularity and an elastography score of 2, and a giant heterogeneous hypervascular left breast mass with enlarged axillary lymph nodes and an elastography score of 4. Interventions: After multidisciplinary review, the patient underwent excision of the right breast mass with frozen-section margin assessment, left total mastectomy including the nipple-areola complex and ulcerated skin to achieve negative margins, and level I-II axillary lymph node dissection because sentinel lymph node biopsy was considered unreliable in the setting of massive ulceration and severe axillary edema. Outcomes: Recovery was uneventful. Ceftriaxone sodium 2.0 g was given intravenously once daily from 1 day before surgery through postoperative day 5. No wound infection, seroma, fever, or unexpected adverse events occurred. At 1 month, CA125, CA15-3, and CA19-9 had normalized. Lessons: In phyllodes tumors, marked axillary FDG avidity may reflect reactive inflammation rather than true nodal metastasis, particularly in giant ulcerated tumors with necrosis. Management should emphasize complete excision with negative margins and cautious axillary surgery guided by clinicopathologic correlation.

Indexed as

18F-FDG PET-CTaxillary lymph nodesbreastcase reportPhyllodes tumorsynchronous bilateral

Identifiers

PMID42088215
PMCPMC13135942

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.